5q-综合征生存23年1例  

Twenty-three years surviving in a patient with del(5q)myelodysplastic syndrome

作　　者：李盼盼[1] 李军[1] 林玉梅[1] 

机构地区：[1]吉林大学中日联谊医院肿瘤.血液科,长春130033

出　　处：《临床血液学杂志》2015年第5期806-807,共2页Journal of Clinical Hematology

摘　　要：<正>1病例资料患者,女,63岁,因进行性乏力、面色苍白4个月于1991年来我院就诊。当时体检:重度贫血貌,淋巴结、肝、脾无肿大。血常规示:WBC 5.9×109/L,Hb 51g/L,PLT 539×109/L,多次骨穿检查示骨髓增生活跃至明显活跃,粒红比例大致正常,淋巴细胞比例不高,巨核细胞不少,可见粒红巨三系病态造血,诊断骨髓增生异常综合征(MDS)-RA型,曾先后间断单药或2~3药联合应用雄激素。Summary We report the case of a 63-year-old female diagnosed with myelodysplastic syndrome and deletion in 5q surviving for 23 years. The patient received traditional medicine therapy continuously for more than 15 years and suffered disease progression several times. Then she received lenalidomide treatment during the latest 7 years and the disease was well-controlled now. The manifestation, diagnosis and treatment of de/（Sq） myelodysplastic syndrome were discussed and the application of lenalidomide was highlighted in this artical.

关 键 词：5Q-综合征 来那度胺 

分 类 号：R551.3[医药卫生—血液循环系统疾病]